Donald W. Grimm

Biography

 Mr. Grimm has served as a Director with Hamilton Bioventures since August 2001. Since June 1995 he has served as Chairman and President of Strategic Design LLC, a strategic planning and consulting company. Mr. Grimm retired from Eli Lilly & Company, a research-based pharmaceutical company, in December 1993 after 23 years of service. Mr. Grimm held positions at Eli Lilly as Director of Worldwide Pharmaceutical Pricing, Director of Pharmaceutical Market Research, and Director of Sales. Following these assignments, Mr. Grimm was President & Chief Executive Officer of Hybritech, Inc., a wholly owned subsidiary of Lilly. In addition, he is currently a Director of several private and public companies, including Life Technologies Corp., Angstrom, CellzDirect, HTG and ACS. Mr. Grimm received his B.S. in Pharmacy and his M.B.A. from the University of Pittsburgh.

Research Interest

 Cosmetology & Oro Facial Surgery